1. Home
  2. Labeler Index
  3. Zydus Pharmaceuticals Usa Inc.
  4. 70710-1745
  5. NDC Package Code: 70710-1745-3 Dasatinib

NDC Package 70710-1745-3 Dasatinib

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70710-1745-3
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
70710-1745
Proprietary Name:
Dasatinib
Non-Proprietary Name:
Dasatinib
Substance Name:
Dasatinib
Usage Information:
This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
70710174503
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Zydus Pharmaceuticals Usa Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
DASATINIB 100 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA218719
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
03-03-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70710-1745-3?

The NDC Packaged Code 70710-1745-3 is assigned to a package of 30 tablet in 1 bottle of Dasatinib, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 70710-1745 included in the NDC Directory?

Yes, Dasatinib with product code 70710-1745 is active and included in the NDC Directory. The product was first marketed by Zydus Pharmaceuticals Usa Inc. on March 03, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70710-1745-3?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 70710-1745-3?

The 11-digit format is 70710174503. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170710-1745-35-4-270710-1745-03